Silverback Therapeutics shares owned by Bank of America Corporation
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Bank of America Corporation
from 13F filings
Historical chart of Bank of America Corporation investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Silverback Therapeutics by Bank of America Corporation
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $1.7M | 161k | 10.55 |
2024-09-30 | $2.6M | 180k | 14.50 |
2024-06-30 | $920k | 108k | 8.51 |
2024-03-31 | $834k | 82k | 10.22 |
2023-12-31 | $540k | 99k | 5.48 |
2023-09-30 | $213k | 56k | 3.78 |
2023-06-30 | $177k | 26k | 6.70 |
2023-03-31 | $160k | 25k | 6.51 |
2022-12-31 | $113k | 13k | 8.53 |
2022-06-30 | $1.0M | 243k | 4.24 |
2021-12-31 | $158k | 24k | 6.65 |
2021-06-30 | $1.0M | 33k | 30.88 |
2021-03-31 | $1.2M | 27k | 43.59 |
More positions owned by Bank of America Corporation
View all positions for Bank of America Corporation